Table 2 Treatment details
EBRT* central pelvic dose (Gy) | Median (range) | 30 (20-50) |
HDR-ICBT†dose for point A | Median (range) | 24 (12-30) |
Applicor type | Tandem + ovoid | 42 |
| Â | Tandem + cylinder | 9 |
Concurrent chemotheraphy | Yes | 30 |
| Â | No | 21 |
TTT††(days) | Median (range) | 42 (36-67) |
Volume of HR-CTV at first ICBT (ml) | Median (range) | 23.3 (8.3-100.8) |
Maximum diameter of HR-CTV at first ICBT (mm) | Median (range) | 46.9 (32.2-77.5) |
Maximum length from tandem to edge of HR-CTV at first ICBT (mm) | Median (range) | 29.2 (18.0-51.9) |
EQD2 ll of point A | Median (range) | 62 (52-72.3) |
EQD2 ll of HR-CTV D90 ** | Media (range) | 65.0 (52.7-101.7) |